ciprofloxacin has been researched along with Bladder Cancer in 15 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral ciprofloxacin might achieve higher concentration in urine than in serum; theoretically, this drug might act as an anticancer drug against bladder cancer cells." | 8.86 | Ciprofloxacin criteria in antimicrobial prophylaxis and bladder cancer recurrence. ( Drewa, T; Gurtowska, N; Kloskowski, T, 2010) |
| "The disruption of calcium homeostasis, mitochondrial swelling and redistribution of Bax to the mitochondrial membrane are key events in the initiation of apoptotic processes in ciprofloxacin treated bladder cancer cells." | 7.71 | Role of mitochondria in ciprofloxacin induced apoptosis in bladder cancer cells. ( Alhasan, S; Aranha, O; Kuo, TH; Sarkar, FH; Wood, DP; Zhu, L, 2002) |
| "The results of this study show that both ciprofloxacin, chosen for its use as possible radiosensitizing agent in bladder cancer patients, and hydrocortisone, chosen as an example of lypofilic endogenous compound, can be absorbed through the intestinal mucosa of a continent ileal reservoir, but to a different extent and with high interindividual variability." | 5.12 | Interindividual variability in the absorption of ciprofloxacin and hydrocortisone from continent ileal reservoir for urine. ( Corbu, C; Garbero, C; Gosmar, M; Manfredi, V; Martelli, A; Mattioli, F; Tognoni, P, 2006) |
| "Oral ciprofloxacin might achieve higher concentration in urine than in serum; theoretically, this drug might act as an anticancer drug against bladder cancer cells." | 4.86 | Ciprofloxacin criteria in antimicrobial prophylaxis and bladder cancer recurrence. ( Drewa, T; Gurtowska, N; Kloskowski, T, 2010) |
| "The disruption of calcium homeostasis, mitochondrial swelling and redistribution of Bax to the mitochondrial membrane are key events in the initiation of apoptotic processes in ciprofloxacin treated bladder cancer cells." | 3.71 | Role of mitochondria in ciprofloxacin induced apoptosis in bladder cancer cells. ( Alhasan, S; Aranha, O; Kuo, TH; Sarkar, FH; Wood, DP; Zhu, L, 2002) |
| "Four patients had had cervical cancer, five had uterine cancer, one had prostatic cancer, one had vesical cancer and one had vaginal cancer." | 1.37 | A novel treatment for haemorrhagic radiation proctitis using colonic irrigation and oral antibiotic administration. ( Atittharnsakul, P; Patiwongpaisarn, A; Rojanasakul, A; Sahakitrungruang, C; Thum-Umnuaysuk, S, 2011) |
| "The recurrence rate for superficial bladder tumors treated with complete resection averages 88%." | 1.32 | Antitumor activity of common antibiotics against superficial bladder cancer. ( Kamat, AM; Lamm, DL, 2004) |
| "Ciprofloxacin (200 mg) was administered iv, and intestinal samples were collected over a 120-min period." | 1.31 | Transepithelial intestinal excretion of ciprofloxacin in humans. ( Ben-Haim, M; Ramon, J; Rubinstein, E; Shabtai, M, 2001) |
| "Ciprofloxacin and ofloxacin inhibit proliferation and DNA synthesis of these 3 human TCC lines in vitro." | 1.29 | Inhibition of human transitional cell carcinoma in vitro proliferation by fluoroquinolone antibiotics. ( Dixon, PS; Peretsman, SJ; Seay, TM, 1996) |
| "Ciprofloxacin was tested for its effect on proliferation of a bladder carcinoma cell line, Jurkat T-cell leukaemia cell line and a normal human foreskin derived from a fibroblast cell line." | 1.28 | The inhibitory effect of ciprofloxacin on proliferation of a murine bladder carcinoma cell line. ( Shalit, I; Zehavi-Willner, T, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, H | 1 |
| Cao, X | 1 |
| Zhang, W | 1 |
| Li, Q | 1 |
| Gurtowska, N | 1 |
| Kloskowski, T | 1 |
| Drewa, T | 1 |
| Sahakitrungruang, C | 1 |
| Thum-Umnuaysuk, S | 1 |
| Patiwongpaisarn, A | 1 |
| Atittharnsakul, P | 1 |
| Rojanasakul, A | 1 |
| Durek, C | 1 |
| Jurczok, A | 1 |
| Werner, H | 1 |
| Jocham, D | 1 |
| Bohle, A | 1 |
| Kamat, AM | 2 |
| Lamm, DL | 2 |
| Mattioli, F | 1 |
| Tognoni, P | 1 |
| Manfredi, V | 1 |
| Gosmar, M | 1 |
| Corbu, C | 1 |
| Garbero, C | 1 |
| Martelli, A | 1 |
| Burgués, JP | 1 |
| Gómez, L | 1 |
| Pontones, JL | 1 |
| Vera, CD | 1 |
| Jiménez-Cruz, JF | 1 |
| Ozonas, M | 1 |
| Seay, TM | 1 |
| Peretsman, SJ | 1 |
| Dixon, PS | 1 |
| Ebisuno, S | 1 |
| Inagaki, T | 1 |
| Kohjimoto, Y | 1 |
| Ohkawa, T | 1 |
| Beatty, JA | 1 |
| Martin, P | 1 |
| Kendall, K | 1 |
| Malik, R | 1 |
| DeHaven, JI | 1 |
| Aranha, O | 2 |
| Wood, DP | 2 |
| Sarkar, FH | 2 |
| Ramon, J | 1 |
| Ben-Haim, M | 1 |
| Shabtai, M | 1 |
| Rubinstein, E | 1 |
| Zhu, L | 1 |
| Alhasan, S | 1 |
| Kuo, TH | 1 |
| Zehavi-Willner, T | 1 |
| Shalit, I | 1 |
1 review available for ciprofloxacin and Bladder Cancer
| Article | Year |
|---|---|
Ciprofloxacin criteria in antimicrobial prophylaxis and bladder cancer recurrence.
Topics: Anti-Infective Agents; Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Line, Tumor; Ciprof | 2010 |
1 trial available for ciprofloxacin and Bladder Cancer
| Article | Year |
|---|---|
Interindividual variability in the absorption of ciprofloxacin and hydrocortisone from continent ileal reservoir for urine.
Topics: Administration, Intravesical; Aged; Analysis of Variance; Carcinoma, Transitional Cell; Ciprofloxaci | 2006 |
13 other studies available for ciprofloxacin and Bladder Cancer
| Article | Year |
|---|---|
Co-existence of two ciprofloxacin-resistant Salmonella enterica serovar Kentucky strains in the urine of a bladder cancer patient.
Topics: Ciprofloxacin; Humans; Kentucky; Salmonella enterica; Serogroup; Urinary Bladder Neoplasms | 2022 |
A novel treatment for haemorrhagic radiation proctitis using colonic irrigation and oral antibiotic administration.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Combined Modality Therapy; Female; Ga | 2011 |
Optimal treatment of systemic bacillus Calmette-Guérin infection: investigations in an animal model.
Topics: Animals; Cell Survival; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Dru | 2002 |
Antitumor activity of common antibiotics against superficial bladder cancer.
Topics: Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Cefazolin; Cell Line, Tumor; Ciprofloxaci | 2004 |
A chemosensitivity test for superficial bladder cancer based on three-dimensional culture of tumour spheroids.
Topics: Antineoplastic Agents; Ciprofloxacin; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, | 2007 |
Inhibition of human transitional cell carcinoma in vitro proliferation by fluoroquinolone antibiotics.
Topics: Anti-Infective Agents; Carcinoma, Transitional Cell; Cell Division; Ciprofloxacin; Dose-Response Rel | 1996 |
The cytotoxic effect of fleroxacin and ciprofloxacin on transitional cell carcinoma in vitro.
Topics: Animals; Anti-Infective Agents; Carcinoma, Transitional Cell; Cell Count; Cell Division; Cell Surviv | 1997 |
Haematuria in a geriatric cat.
Topics: Animals; Anti-Infective Agents; Azure Stains; Carcinoma, Transitional Cell; Cat Diseases; Cats; Cipr | 1999 |
Quinolone antibiotics: a potential adjunct to intravesical chemotherapy for bladder cancer.
Topics: Anti-Infective Agents; Antineoplastic Agents; Carcinoma, Transitional Cell; Ciprofloxacin; Dose-Resp | 1999 |
Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line.
Topics: Apoptosis; bcl-2-Associated X Protein; Carcinoma, Transitional Cell; CDC2-CDC28 Kinases; Cell Cycle; | 2000 |
Transepithelial intestinal excretion of ciprofloxacin in humans.
Topics: Aged; Anti-Infective Agents; Cecum; Ciprofloxacin; Colonic Neoplasms; Female; Humans; Ileum; Intesti | 2001 |
Role of mitochondria in ciprofloxacin induced apoptosis in bladder cancer cells.
Topics: Anti-Infective Agents; Apoptosis; bcl-2-Associated X Protein; Calcium; Carcinoma, Transitional Cell; | 2002 |
The inhibitory effect of ciprofloxacin on proliferation of a murine bladder carcinoma cell line.
Topics: Animals; Antineoplastic Agents; Cell Division; Ciprofloxacin; Fibroblasts; Humans; Kinetics; Lymphom | 1992 |